Rearrangement of energetic and substrate utilization networks compensate for chronic myocardial creatine kinase deficiency

Journal of Physiology

Volumn 589, Issue 21, 2011, Pages 5193-5211

  Dzeja, Petras P ^a   Hoyer, Kirsten ^b   Tian, Rong ^b   Zhang, Song ^a   Nemutlu, Emirhan ^a   Spindler, Matthias ^b   Ingwall, Joanne S ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; CREATINE KINASE; CREATINE PHOSPHATE; CYTOSOLIC CREATINE KINASE; GLUCOSE 6 PHOSPHATE; GUANOSINE TRIPHOSPHATE; PHOSPHATE; SARCOMERIC MITOCHONDRIAL CREATINE KINASE; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ENERGY METABOLISM; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE UTILIZATION; GLYCOLYSIS; HEART MUSCLE; METABOLOMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENYLATE KINASE; ANIMALS; CREATINE KINASE, MB FORM; CREATINE KINASE, MITOCHONDRIAL FORM; GLUCOSE; GLUCOSE TOLERANCE TEST; GLYCOLYSIS; GUANINE NUCLEOTIDES; METABOLOMICS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA, HEART; MUSCLE, SKELETAL; MYOCARDIUM;

EID: 80054978355     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.212829     Document Type: Article

References (103)

1. Abraham MR, Selivanov VA, Hodgson DM, Pucar D, Zingman LV, Wieringa B et al (2002). Coupling of cell energetics with membrane metabolic sensing. Integrative signaling through creatine kinase phosphotransfer disrupted by M-CK gene knock-out. J Biol Chem 277, 24427-24434.
2. Agnetti G, Husberg C & Van Eyk JE (2011). Divide and conquer: the application of organelle proteomics to heart failure. Circ Res 108, 512-526.
3. Aksentijevic D, Lygate CA, Makinen K, Zervou S, Sebag-Montefiore L, Medway D et al (2010). High-energy phosphotransfer in the failing mouse heart: role of adenylate kinase and glycolytic enzymes. Eur J Heart Fail 12, 1282-1289.
4. Ashrafian H & Neubauer S (2009). Metabolomic profiling of cardiac substrate utilization: fanning the flames of systems biology? Circulation 119, 1700-1702.
5. Balaban RS, Kantor HL, Katz LA & Briggs RW (1986). Relation between work and phosphate metabolite in the in vivo paced mammalian heart. Science 232, 1121-1123.
6. 31P NMR study in the human. FEBS Lett 269, 402-405.
7. Boehm E, Ventura-Clapier R, Mateo P, Lechene P & Veksler V (2000). Glycolysis supports calcium uptake by the sarcoplasmic reticulum in skinned ventricular fibres of mice deficient in mitochondrial and cytosolic creatine kinase. J Mol Cell Cardiol 32, 891-902.
8. Bose S, French S, Evans FJ, Joubert F & Balaban RS (2003). Metabolic network control of oxidative phosphorylation: multiple roles of inorganic phosphate. J Biol Chem 278, 39155-39165.
9. Bottomley PA, Wu KC, Gerstenblith G, Schulman SP, Steinberg A & Weiss RG (2009). Reduced myocardial creatine kinase flux in human myocardial infarction: an in vivo phosphorus magnetic resonance spectroscopy study. Circulation 119, 1918-1924.
10. Bovill E, Westaby S, Crisp A, Jacobs S & Shaw T (2009). Reduction of four-and-a-half LIM-protein 2 expression occurs in human left ventricular failure and leads to altered localization and reduced activity of metabolic enzymes. J Thorac Cardiovasc Surg 137, 853-861.
11. Bruton JD, Dahlstedt AJ, Abbate F & Westerblad H (2003). Mitochondrial function in intact skeletal muscle fibres of creatine kinase deficient mice. J Physiol 552, 393-402.
12. Cha YM, Dzeja PP, Redfield MM, Shen WK & Terzic A (2006). Bioenergetic protection of failing atrial and ventricular myocardium by vasopeptidase inhibitor omapatrilat. Am J Physiol Heart Circ Physiol 290, H1686-H1692.
13. Cha YM, Dzeja PP, Shen WK, Jahangir A, Hart CY, Terzic A & Redfield MM (2003). Failing atrial myocardium: energetic deficits accompany structural remodeling and electrical instability. Am J Physiol Heart Circ Physiol 284, H1313-H1320.
14. Chung S, Arrell DK, Faustino RS, Terzic A & Dzeja PP (2010). Glycolytic network restructuring integral to the energetics of embryonic stem cell cardiac differentiation. J Mol Cell Cardiol 48, 725-734.
15. Crozatier B, Badoual T, Boehm E, Ennezat PV, Guenoun T, Su J et al (2002). Role of creatine kinase in cardiac excitation-contraction coupling: studies in creatine kinase-deficient mice. FASEB J 16, 653-660.
16. Dahlstedt AJ, Katz A, Tavi P & Westerblad H (2003). Creatine kinase injection restores contractile function in creatine-kinase-deficient mouse skeletal muscle fibres. J Physiol 547, 395-403.
17. 18O from water. Biophy J 55, 79-99.
18. de Groof AJ, Oerlemans FT, Jost CR & Wieringa B (2001). Changes in glycolytic network and mitochondrial design in creatine kinase-deficient muscles. Muscle Nerve 24, 1188-1196.
19. Drummond GB (2009). Reporting ethical matters in The Journal of Physiology: standards and advice. J Physiol 587, 713-719.
20. Dzeja P, Chung S & Terzic A (2007a). Integration of adenylate kinase, glycolytic and glycogenolytic circuits in cellular energetics. In Molecular System Bioenergetics: Energy for Life, ed. Saks V, pp. 265-301. Wiley-VCH, Weinheim, Germany.
21. Dzeja P & Terzic A (2009). Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing. Int J Mol Sci 10, 1729-1772.
22. Dzeja PP, Bast P, Pucar D, Wieringa B & Terzic A (2007b). Defective metabolic signaling in adenylate kinase AK1 gene knock-out hearts compromises post-ischemic coronary reflow. J Biol Chem 282, 31366-31372.
23. Dzeja PP, Bortolon R, Perez-Terzic C, Holmuhamedov EL & Terzic A (2002). Energetic communication between mitochondria and nucleus directed by catalyzed phosphotransfer. Proc Natl Acad Sci U S A 99, 10156-10161.
24. Dzeja PP, Redfield MM, Burnett JC & Terzic A (2000). Failing energetics in failing hearts. Curr Cardiol Reps 2, 212-217.
25. Dzeja PP & Terzic A (2003). Phosphotransfer networks and cellular energetics. J Exp Biol 206, 2039-2047.
26. Dzeja PP & Terzic A (2007). Mitochondria-nucleus energetic communication: role for phosphotransfer networks in processing cellular information. In Brain Energetics: Integration of Molecular and Cellular Processes, ed. Gibson G & Dienel G, pp. 641-666. Springer, New York.
27. Dzeja PP, Terzic A & Wieringa B (2004). Phosphotransfer dynamics in skeletal muscle from creatine kinase gene-deleted mice. Mol Cell Biochem 256-257, 13-27.
28. Dzeja PP, Vitkevicius KT, Redfield MM, Burnett JC & Terzic A (1999). Adenylate kinase-catalyzed phosphotransfer in the myocardium increased contribution in heart failure. Circ Res 84, 1137-1143.
29. Dzeja PP, Zeleznikar RJ & Goldberg ND (1996). Suppression of creatine kinase-catalyzed phosphotransfer results in increased phosphoryl transfer by adenylate kinase in intact skeletal muscle. J Biol Chem 271, 12847-12851.
30. Dzeja PP, Zeleznikar RJ & Goldberg ND (1998). Adenylate kinase: kinetic behavior in intact cells indicates it is integral to multiple cellular processes. Mol Cell Biochem 184, 169-182.
31. Feala JD, Coquin L, Paternostro G & McCulloch AD (2008). Integrating metabolomics and phenomics with systems models of cardiac hypoxia. Prog Biophys Mol Biol 96, 209-225.
32. Feala JD, Coquin L, Zhou D, Haddad GG, Paternostro G & McCulloch AD (2009). Metabolism as means for hypoxia adaptation: metabolic profiling and flux balance analysis. BMC Syst Biol 3, 91.
33. Fujisawa K, Murakami R, Horiguchi T & Noma T (2009). Adenylate kinase isozyme 2 is essential for growth and development of Drosophila melanogaster. Comp Biochem Physiol B Biochem Mol Biol 153, 29-38.
34. Gohil VM, Sheth SA, Nilsson R, Wojtovich AP, Lee JH, Perocchi F et al (2010). Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis. Nat Biotechnol 28, 249-255.
35. Hardie DG (2011). AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer. Biochem Soc Trans 39, 1-13.
36. Hippe HJ, Wolf NM, Abu-Taha I, Mehringer R, Just S, Lutz S et al (2009). The interaction of nucleoside diphosphate kinase B with Gbg dimers controls heterotrimeric G protein function. Proc Natl Acad Sci U S A 106, 16269-16274.
37. 31P NMR study. Metab Eng 6, 36-43.
38. Ingwall JS (1991). Whole-organ enzymology of the creatine kinase system in heart. Biochem Soc Trans 19, 1006-1010.
39. Ingwall JS (2004). Transgenesis and cardiac energetics: new insights into cardiac metabolism. J Mol Cell Cardiol 37, 613-623.
40. Ingwall JS (2006). Energetics of the failing heart: new insights using genetic modification in the mouse. Arch Mal Coeur Vaiss 99, 839-847.
41. Ingwall JS (2009). Energy metabolism in heart failure and remodelling. Cardiovasc Res 81, 412-419.
42. Ingwall JS, Kramer MF, Fifer MA, Lorell BH, Shemin R, Grossman W & Allen PD (1985). The creatine kinase system in normal and diseased human myocardium. N Engl J Med 313, 1050-1054.
43. Ingwall JS & Shen W (2010). On energy circuits in the failing myocardium. Eur J Heart Fail 12, 1268-1270.
44. Janssen E, Dzeja PP, Oerlemans F, Simonetti AW, Heerschap A, de Haan A et al (2000). Adenylate kinase 1 gene deletion disrupts muscle energetic economy despite metabolic rearrangement. EMBO J 19, 6371-6381.
45. Janssen E, Terzic A, Wieringa B & Dzeja PP (2003). Impaired intracellular energetic communication in muscles from creatine kinase and adenylate kinase (M-CK/AK1) double knock-out mice. J Biol Chem 278, 30441-30449.
46. Jeninga EH, Schoonjans K & Auwerx J (2010). Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility. Oncogene 29, 4617-4624.
47. Jones RG & Thompson CB (2009). Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev 23, 537-548.
48. 3H]adenine: field comparison. Appl Environ Microbiol 50, 706-709.
49. Katz A, Andersson DC, Yu J, Norman B, Sandstrom ME, Wieringa B & Westerblad H (2003). Contraction-mediated glycogenolysis in mouse skeletal muscle lacking creatine kinase: the role of phosphorylase b activation. J Physiol 553, 523-531.
50. 31P-NMR study of isolated rat hearts. Am J Physiol Heart Circ Physiol 261, H469-H478.
51. Kolwicz SC Jr & Tian R (2009). Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization? Trends Cardiovasc Med 19, 201-207.
52. Kuiper JW, van Horssen R, Oerlemans F, Peters W, van Dommelen MM, te Lindert MM et al (2009). Local ATP generation by brain-type creatine kinase (CK-B) facilitates cell motility. PLoS ONE 4, e5030.
53. Lacombe ML, Tokarska-Schlattner M, Epand RF, Boissan M, Epand RM & Schlattner U (2009). Interaction of NDPK-D with cardiolipin-containing membranes: structural basis and implications for mitochondrial physiology. Biochimie 91, 779-783.
54. Lagresle-Peyrou C, Six EM, Picard C, Rieux-Laucat F, Michel V, Ditadi A et al (2009). Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness. Nat Genet 41, 106-111.
55. Lange S, Auerbach D, McLoughlin P, Perriard E, Schafer BW, Perriard JC & Ehler E (2002). Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2. J Cell Sci 115, 4925-4936.
56. 1H-nuclear magnetic spectroscopy followed by principal component analysis and hierarchical cluster analysis to demonstrate effects of statins on hyperlipidemic patients. NMR Biomed 18, 421-429.
57. Luptak I, Yan J, Cui L, Jain M, Liao R & Tian R (2007). Long-term effects of increased glucose entry on mouse hearts during normal aging and ischemic stress. Circulation 116, 901-909.
58. Malliaras KG, Terrovitis JV, Drakos SG & Nanas JN (2009). Reverse cardiac remodeling enabled by mechanical unloading of the left ventricle. J Cardiovasc Transl Res 2, 114-125.
59. 13C NMR spectroscopy. J Biol Chem 263, 6964-6971.
60. 13C isotope isomers. Am J Physiol Heart Circ Physiol 259, H987-H995.
61. 13C isotopic tracers for metabolic flux analysis in mammalian cells. J Biotechnol 144, 167-174.
62. Nahrendorf M, Streif JU, Hiller KH, Hu K, Nordbeck P, Ritter O et al (2006). Multimodal functional cardiac MRI in creatine kinase-deficient mice reveals subtle abnormalities in myocardial perfusion and mechanics. Am J Physiol Heart Circ Physiol 290, H2516-H2521.
63. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W et al (1997). Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96, 2190-2196.
64. Nicolay K, van Dorsten FA, Reese T, Kruiskamp MJ, Gellerich JF & van Echteld CJ (1998). In situ measurements of creatine kinase flux by NMR. The lessons from bioengineered mice. Mol Cell Biochem 184, 195-208.
65. Noma T (2005). Dynamics of nucleotide metabolism as a supporter of life phenomena. J Med Invest 52, 127-136.
66. Obrzut S, Tiongson J, Jamshidi N, Phan HM, Hoh C & Birgersdotter-Green U (2010). Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy. J Cardiovasc Transl Res 3, 643-651.
67. Olson LK, Schroeder W, Robertson RP, Goldberg ND & Walseth TF (1996). Suppression of adenylate kinase catalyzed phosphotransfer precedes and is associated with glucose-induced insulin secretion in intact HIT-T15 cells. J Biol Chem 271, 16544-16552.
68. Pannicke U, Honig M, Hess I, Friesen C, Holzmann K, Rump EM et al (2009). Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nat Genet 41, 101-105.
69. Phillips D, Ten Hove M, Schneider JE, Wu CO, Sebag-Montefiore L, Aponte AM et al (2010). Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacity. J Mol Cell Cardiol 48, 582-590.
70. Pucar D, Bast P, Gumina RJ, Lim L, Drahl C, Juranic N et al (2002). Adenylate kinase AK1 knockout heart: energetics and functional performance under ischemia-reperfusion. Am J Physiol Heart Circ Physiol 283, H776-H782.
71. 1H NMR spectroscopy. Mol Cell Biochem 256-257, 281-289.
72. 31P NMR. J Biol Chem 276, 44812-44819.
73. Pucar D, Janssen E, Dzeja PP, Juranic N, Macura S, Wieringa B & Terzic A (2000). Compromised energetics in the adenylate kinase AK1 gene knockout heart under metabolic stress. J Biol Chem 275, 41424-41429.
74. Rayens WS & Andersen AH (2006). Multivariate analysis of fMRI data by oriented partial least squares. Magn Reson Imaging 24, 953-958.
75. 32P labelling of the nucleotides in alpha-position in the rabbit heart. J Mol Cell Cardiol 7, 891-906.
76. Saks V, Dzeja P, Schlattner U, Vendelin M, Terzic A & Wallimann T (2006). Cardiac system bioenergetics: metabolic basis of the Frank-Starling law. J Physiol 571, 253-273.
77. Saks V, Monge C, Anmann T & Dzeja P (2007). Integrated and organized cellular energetic systems: theories of cell energetics, compartmentation and metabolic channeling. In Molecular System Bioenergetics: Energy for Life, ed. Saks V, pp. 59-109. Wiley-VCH, Weinheim, Germany.
78. Saks VA, Khuchua ZA, Vasilyeva EV, Belikova O & Kuznetsov AV (1994). Metabolic compartmentation and substrate channelling in muscle cells. Role of coupled creatine kinases in in vivo regulation of cellular respiration-a synthesis. Mol Cell Biochem 133-134, 155-192.
79. Saupe KW, Spindler M, Hopkins JC, Shen W & Ingwall JS (2000). Kinetic, thermodynamic, and developmental consequences of deleting creatine kinase isoenzymes from the heart. Reaction kinetics of the creatine kinase isoenzymes in the intact heart. J Biol Chem 275, 19742-19746.
80. Saupe KW, Spindler M, Tian R & Ingwall JS (1998). Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase. Circ Res 82, 898-907.
81. Shen W, Spindler M, Higgins MA, Jin N, Gill RM, Bloem LJ et al (2005). The fall in creatine levels and creatine kinase isozyme changes in the failing heart are reversible: complex post-transcriptional regulation of the components of the CK system. J Mol Cell Cardiol 39, 537-544.
82. Spindler M, Meyer K, Stromer H, Leupold A, Boehm E, Wagner H & Neubauer S (2004). Creatine kinase-deficient hearts exhibit increased susceptibility to ischemia-reperfusion injury and impaired calcium homeostasis. Am J Physiol Heart Circ Physiol 287, H1039-H1045.
83. Spindler M, Niebler R, Remkes H, Horn M, Lanz T & Neubauer S (2002). Mitochondrial creatine kinase is critically necessary for normal myocardial high-energy phosphate metabolism. Am J Physiol Heart Circ Physiol 283, H680-H687.
84. 2+ responses in muscles with combined mitochondrial and cytosolic creatine kinase deficiencies. Cell 89, 93-103.
85. Taegtmeyer H, Goodwin GW, Doenst T & Frazier OH (1997). Substrate metabolism as a determinant for postischemic functional recovery of the heart. Am J Cardiol 80, 3A-10A.
86. ten Hove M, Lygate CA, Fischer A, Schneider JE, Sang AE, Hulbert K et al (2005). Reduced inotropic reserve and increased susceptibility to cardiac ischemia/reperfusion injury in phosphocreatine-deficient guanidinoacetate-N-methyltransferase-knockout mice. Circulation 111, 2477-2485.
87. Tian R (2003). Transcriptional regulation of energy substrate metabolism in normal and hypertrophied heart. Curr Hypertens Rep 5, 454-458.
88. Titman CM, Downs JA, Oliver SG, Carmichael PL, Scott AD & Griffin JL (2009). A metabolomic and multivariate statistical process to assess the effects of genotoxins in Saccharomyces cerevisiae. Mol Biosyst 5, 1913-1924.
89. van Deursen J, Heerschap A, Oerlemans F, Ruitenbeek W, Jap P, ter Laak H & Wieringa B (1993). Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity. Cell 74, 621-631.
90. Ventura-Clapier R, Garnier A, Veksler V & Joubert F (2010). Bioenergetics of the failing heart. Biochim Biophys Acta 1813, 1360-1372.
91. Ventura-Clapier R, Kaasik A & Veksler V (2004). Structural and functional adaptations of striated muscles to CK deficiency. Mol Cell Biochem 256-257, 29-41.
92. Ventura-Clapier R, Kuznetsov AV, d'Albis A, van Deursen J, Wieringa B & Veksler VI (1995). Muscle creatine kinase-deficient mice. I. Alterations in myofibrillar function. J Biol Chem 270, 19914-19920.
93. Wallimann T, Wyss M, Brdiczka D, Nicolay K & Eppenberger HM (1992). Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J 281, 21-40.
94. Wiechert W & de Graaf AA (1997). Bidirectional reaction steps in metabolic networks: I. Modeling and simulation of carbon isotope labeling experiments. Biotechnol Bioeng 55, 101-117.
95. Wyss M, Braissant O, Pischel I, Salomons GS, Schulze A, Stockler S & Wallimann T (2007). Creatine and creatine kinase in health and disease - a bright future ahead? Subcell Biochem 46, 309-334.
96. Xiong Q, Du F, Zhu X, Zhang P, Suntharalingam P, Ippolito J et al (2011). ATP production rate via creatine kinase or ATP synthase in vivo: a novel superfast magnetization saturation transfer method. Circ Res 108, 653-663.
97. Yang YC, Fann MJ, Chang WH, Tai LH, Jiang JH & Kao LS (2010). Regulation of sodium-calcium exchanger activity by creatine kinase under energy-compromised conditions. J Biol Chem 285, 28275-28285.
98. Ye Y, Gong G, Ochiai K, Liu J & Zhang J (2001). High-energy phosphate metabolism and creatine kinase in failing hearts: a new porcine model. Circulation 103, 1570-1576.
99. Zeleznikar RJ, Dzeja PP & Goldberg ND (1995). Adenylate kinase-catalyzed phosphoryl transfer couples ATP utilization with its generation by glycolysis in intact muscle. J Biol Chem 270, 7311-7319.
100. 18O labeling of metabolite phosphoryls. J Biol Chem 266, 15110-15119.
101. Zeleznikar RJ, Heyman RA, Graeff RM, Walseth TF, Dawis SM, Butz EA & Goldberg ND (1990). Evidence for compartmentalized adenylate kinase catalysis serving a high energy phosphoryl transfer function in rat skeletal muscle. J Biol Chem 265, 300-311.
102. +/- transgenic mice: effect of physical stress. Circulation 122, A20435.
103. Zilversmit DB, Entenman C & Fishler MC (1943). On the calculation of "turnover time" and "turnover rate" from experiments involving the use of labeling agents. J Gen Physiol 26, 325-331.